DGAP-News: Celesio AG / Key word(s): Change of Personnel
Celesio AG: Changes in management of Celesio AG
22.05.2014 / 13:29
---------------------------------------------------------------------
Changes in management of Celesio AG
Stuttgart, 22 May 2014. The Supervisory Board of Celesio AG today appointed
Marc Owen, to date President of McKesson Specialty Health and member of the
McKesson Operating Team, and Alain Vachon, to date Senior Vice President
and Chief Financial Officer of McKesson U.S. Pharmaceutical, as new members
of the Management Board of Celesio AG with effect from 16 July 2014. Marc
Owen will take over the position of Chairman of the Management Board and
Alain Vachon will take over the position of Chief Financial Officer.
The current speaker of the Management Board and Chief Financial Officer Dr.
Marion Helmes has by mutual agreement with the Supervisory Board resigned
from her office and terminated her engagement with the Company with effect
as of the end of 15 July 2014. The Chief Operating Officer Martin Fisher
has by mutual agreement with the Supervisory Board also resigned from his
office with effect as of the end of 22 May 2014. Dr. Marion Helmes will
additionally take over the position of interim Chief Operating Officer
until and including 15 July 2014.
The Management Board and the Supervisory Board of Celesio AG today further
resolved to enter into the domination and profit and loss transfer
agreement with Dragonfly GmbH & Co. KGaA, a 100% indirect subsidiary of
McKesson Corporation in line with the terms previously announced (see also
ad hoc announcement of Celesio AG of 14 May 2014). The Agreement is
expected to be executed by both parties today and will be presented to the
Annual General Meeting of Celesio AG for approval on 15 July 2014.
Contacts Celesio Group
Investor Relations:
Markus Georgi, +49 (0)711.5001-1208
investor@celesio.com
Michael Otto, +49 (0)711.5001-635
investor@celesio.com
Media:
Marc Binder, +49 (0)711.5001-380
media@celesio.com
Rainer Berghausen, +49 (0)711.5001-549
media@celesio.com
About Celesio Group
Celesio is a leading international wholesale and retail company and
provider of logistics and services to the pharmaceutical and healthcare
sectors. The proactive and preventive approach ensures that patients
receive the products and support that they require for optimum care. With
some 39,000 employees, Celesio operates in 14 countries around the world.
Every day, the group serves over 2 million customers - at 2,200 pharmacies
of its own and 4,200 participants in brand partnership schemes. With
approximately 130 wholesale branches, Celesio supplies 65,000 pharmacies
and hospitals every day with up to 130,000 pharmaceutical products. The
services benefit a patient pool of about 15 million per day.
End of Corporate News
---------------------------------------------------------------------
22.05.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Celesio AG
Neckartalstr. 155
70376 Stuttgart
Germany
Phone: +49 (0)711 5001-735
Fax: +49 (0)711 5001-740
E-mail: investor@celesio.com
Internet: www.celesio.com
ISIN: DE000CLS1001, DE000CLS1043
WKN: CLS100, CLS104
Indices: MDAX
Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime
Standard), München, Stuttgart; Freiverkehr in Hamburg,
Hannover; Terminbörse EUREX
End of News DGAP News-Service
---------------------------------------------------------------------
270044 22.05.2014
DGAP-News: Celesio AG: Changes in management of Celesio AG
| Source: EQS Group AG